Product News & Updates
Blescath® Launch
Posted On: May 3, 2022BLEScath® Launch May 5, 2022
We are excited to release a first-of-its-kind single-use, unique, intratracheal, thin catheter with an integrated stylet, designed by clinical experts who understand the practice and importance of delivering exogenous pulmonary surfactant to neonates who suffer from Neonatal Respiratory Distress Syndrome (NRDS)2.
Read More >
Health Canada approves BLEScath® for use in Canada.
Posted On: May 3, 2022BLEScath® is intended for the administration of bovine lipid extract surfactant suspension (BLES®) using minimally invasive surfactant therapy (MIST) / less invasive surfactant administration (LISA) technique for rescue treatment of infants with Neonatal Respiratory Distress Syndrome (NRDS)2,3.
Read More >
Poractant alfa versus bovine lipid extract surfactant: Prospective Comparative Effectiveness Study.
Posted On: May 3, 2022Publication Release
Poractant alfa versus bovine lipid extract surfactant: Prospective Comparative Effectiveness Study.
Read More >
SickKids Paediatric Update Conference 2022
Posted On: May 2, 2022SickKids Paediatric Update Conference (PUC) – Virtual
Thursday, May 4, 2022-Saturday, May 7, 2022
Read More >
Canadian Paediatric Society Annual Conference 2022
Posted On: May 2, 2022CPS 2022 Annual Conference – Montreal, PQ
Thursday, May 26 – Saturday, May 28, 2022
Read More >
Canadian National Perinatal Research Meeting 2022
Posted On: May 2, 2022CNPRM – Virtual 2022
Monday, May 30 – Friday, June 3, 2022
Read More >